Sources | Names Used |
---|---|
CTRPv2 | erlotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | erlotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AADACL2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | ABCA10 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.008 |
mRNA | ABCA12 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | ABCA4 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
mRNA | ABCA9 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
mRNA | ABCB4 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
mRNA | ABCF1 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
mRNA | ABHD18 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.001 |
mRNA | ABLIM2 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
mRNA | ABT1 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.02 |